Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Heine Bröring, Renate C ^a   Winkels, Renate M ^a   Botma, Akke ^a   van Duijnhoven, Fränzel J B ^a,b   Jung, Audrey Y ^c   Kleibeuker, Jan H ^d   Nagengast, Fokko M ^c   Vasen, Hans F A ^e   Kampman, Ellen ^a,c,f  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Foundation for the Detection of Hereditary Tumours   (Netherlands)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM; FISH OIL; MULTIVITAMIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; GENDER; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MMR GENE; POPULATION RESEARCH; ADENOMA; COLORECTAL NEOPLASMS; COMPLICATION; DIETARY SUPPLEMENT; GENETICS; MIDDLE AGED; MISMATCH REPAIR; MUTATION; PROSPECTIVE STUDY;

ADENOMA; ADULT; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIETARY SUPPLEMENTS; DNA MISMATCH REPAIR; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES;

EID: 84879146635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066819     Document Type: Article

References (40)

1. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, et al. (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76: 1-18.
2. Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, et al. (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 74: 233-242.
3. Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, et al. (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129: 415-421.
4. Quehenberger F, Vasen HF, van Houwelingen HC, (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42: 491-496.
5. Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, et al. (2006) Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 4: 489-498.
6. Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, et al. (2011) Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 12: 49-55.
7. Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, et al. (2011) Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 32: 407-414.
8. de la Chapelle A, (2005) The incidence of Lynch syndrome. Fam Cancer 4: 233-237.
9. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, et al. (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26: 5783-5788.
10. Rijcken FE, Hollema H, Kleibeuker JH, (2002) Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 50: 382-386.
11. De Jong AE, Morreau H, Van Puijenbroek M, Eilers PH, Wijnen J, et al. (2004) The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 126: 42-48.
12. Signaleringscommissie Kanker van KWF Kankerbestrijding (2007). Signaleringsrapport 'De kans op kanker'. Bewerking van cijfers NKR en CBS 1999-2003. Amsterdam, the Netherlands.
13. American Cancer Society (2008). Colorectal Cancer Facts & Figures 2008-2010. Atlanta.
14. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, et al. (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118: 829-834.
15. Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, et al. (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 138: 2300-2306.
16. (2008) Erfelijke darmkanker- Landelijke richtlijn- Versie 1. Vereniging Klinische Genetica Nederland.
17. Botma A, Nagengast FM, Braem MG, Hendriks JC, Kleibeuker JH, et al. (2010) Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol 28: 4346-4353.
18. Winkels RM, Botma A, Van Duijnhoven FJ, Nagengast FM, Kleibeuker JH, et al. (2011) Smoking Increases the Risk for Colorectal Adenomas in Patients With Lynch Syndrome. Gastroenterology.
19. Botma A, Vasen HF, van Duijnhoven FJ, Kleibeuker JH, Nagengast FM, et al. (2013) Dietary patterns and colorectal adenomas in Lynch syndrome: The GEOLynch cohort study. Cancer 119: 512-521.
20. Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, et al. (2007) Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 5: 736-742.
21. McGinnis JM, Birt DF, Brannon PM, Carroll RJ, Gibbons RD, et al. (2007) National institutes of health state-of-the-science conference statement: Multivitamin/mineral supplements and chronic disease prevention. American Journal of Clinical Nutrition 85: 257s-264s.
22. Ervin RB, Wright JD, Kennedy-Stephenson J (1999) Use of dietary supplements in the United States, 1988-94. Vital Health Stat 11: i-iii, 1-14.
23. Neugut AI, Horvath K, Whelan RL, Terry MB, Garbowski GC, et al. (1996) The effect of calcium and vitamin supplements on the incidence and recurrence of colorectal adenomatous polyps. Cancer 78: 723-728.
24. Figueiredo JC, Mott LA, Giovannucci E, Wu KN, Cole B, et al. (2011) Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. International Journal of Cancer 129: 192-203.
25. Bjelakovic G, Nagorni A, Nikolova D, Simonetti RG, Bjelakovic M, et al. (2006) Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Alimentary Pharmacology & Therapeutics 24: 281-291.
26. Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, et al. (2011) Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Disease 13: 1085-1099.
27. Weingarten MA, Zalmanovici A, Yaphe J (2008) Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database of Systematic Reviews.
28. Carroll C, Booth A, Cooper K (2011) A worked example of "best fit" framework synthesis: A systematic review of views concerning the taking of some potential chemopreventive agents. Bmc Medical Research Methodology 11.
29. Feunekes GI, Van Staveren WA, De Vries JH, Burema J, Hautvast JG, (1993) Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr 58: 489-496.
30. Verkleij-Hagoort AC, de Vries JH, Stegers MP, Lindemans J, Ursem NT, et al. (2007) Validation of the assessment of folate and vitamin B12 intake in women of reproductive age: the method of triads. Eur J Clin Nutr 61: 610-615.
31. Pols MA, Peeters PH, Bueno-De-Mesquita HB, Ocke MC, Wentink CA, et al. (1995) Validity and repeatability of a modified Baecke questionnaire on physical activity. Int J Epidemiol 24: 381-388.
32. Cats A, Kleibeuker JH, van der Meer R, Kuipers F, Sluiter WJ, et al. (1995) Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 87: 598-603.
33. Reddy BS, (2004) Omega-3 fatty acids in colorectal cancer prevention. Int J Cancer 112: 1-7.
34. Calviello G, Serini S, Piccioni E, (2007) n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 14: 3059-3069.
35. Schottenfeld D, Beebe-Dimmer J, (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56: 69-83.
36. Rose DP, Connolly JM, (1999) Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 83: 217-244.
37. Van Rossum CTM, Fransen HP, Verkaik-Kloosterman J, Buurma-Rethans EJM, Ocke MC (2011) Dutch National Food Consumption Survey 2007-2010 Diet of children and adults aged 7 to 69 years. Bilthoven: National Institute for Public Health and the Environment.
38. Satia-Abouta J, Patterson RE, King IB, Stratton KL, Shattuck AL, et al. (2003) Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol 157: 944-954.
39. Patterson RE, Kristal AR, Levy L, McLerran D, White E, (1998) Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol 148: 643-649.
40. Block G, Sinha R, Gridley G, (1994) Collection of dietary-supplement data and implications for analysis. Am J Clin Nutr 59: 232S-239S.